European Cystic Fibrosis Society (ECFS)
Published on European Cystic Fibrosis Society (ECFS) (https://www.ecfs.eu)

Home > The ECFS Basic Science Working Group Session - “Task Force on Personalised Medicine for CF”

The ECFS Basic Science Working Group Session - “Task Force on Personalised Medicine for CF”

The ECFS Basic Science Working Group Session - “Task Force on Personalised Medicine for CF”

The ECFS Basic Science Working Group Session - “Task Force on Personalised Medicine for CF”, will take place on Thursday, 30 March 18:00–19:45 (105 min).

There will be 3 Special Group Discussions:

Group Themes Discussion leaders
1 Validation/ optimization of novel biomarkers Kris De Boeck (NL)
2 Assays for improved endpoints to evaluate novel drugs: intestinal and respiratory organoids Jeffrey Beekman (NL)
3 Novel therapeutic approaches to CF therapies: alternative channels and gene/cell therapies Marcus Mall (DE)

The conclusions of the three sub-groups will be further discussed in the main auditorium at the end of the session.

Your Choice
You may choose only one option
Your Information
Terms & Conditions Privacy policy  Accessibility Sitemap Contact 
© EUROPEAN CYSTIC FIBROSIS SOCIETY 2025. All rights reserved. Website by VidaVia (link is external)
European Cystic Fibrosis Society (ECFS)

Source URL:https://www.ecfs.eu/portugal2017/form/task-force-on-personalised-medicine-for-cf